Date: January 19, 2026 Author: Finterra Research Team Introduction As the opening bell prepares to ring on a new week, all eyes in the industrial sector are fixed on St. Paul. 3M Company (NYSE: MMM), once the poster child for "litigation-induced value traps," has undergone a metamorphosis over the last 24 months. Today, on the [...]
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how research tools & consumables stocks fared in Q3, starting with Danaher (NYSE:DHR).
As of today, January 1, 2026, Abbott Laboratories (NYSE: ABT) stands as one of the most resilient and strategically diversified giants in the global healthcare landscape. While the broader market has been defined by the explosive rise of GLP-1 weight-loss drugs and the volatility of post-pandemic earnings, Abbott has successfully completed a pivot that many [...]
Today’s Date: January 9, 2026 Introduction In the annals of American industrial history, few names carry the weight of DuPont de Nemours, Inc. (NYSE: DD). Once a sprawling conglomerate synonymous with "Better Living Through Chemistry," the DuPont of 2026 is a radically different beast. Following the completion of the Qnity Electronics, Inc. (NYSE: Q) spin-off [...]
LANSING, MI – Shares of Neogen Corporation (NASDAQ: NEOG) experienced a dramatic surge in early trading today, climbing nearly 29% after the food and animal safety leader reported second-quarter fiscal 2026 financial results that blew past Wall Street expectations. The performance marks a definitive "return to growth" for the company, which
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages.
Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Danaher Corp (DHR) shows a strong technical breakout setup, combining a firm uptrend with a tightening price formation for a potential next move higher.
As of December 12, 2025, the financial markets are witnessing a significant "Great Rotation," a pronounced shift of capital from high-growth technology and Artificial Intelligence (AI) stocks to more traditional value sectors and defensive equities. This ongoing recalibration reflects evolving macroeconomic conditions, a reassessment of risk appetite, and a growing
New York, NY – December 9, 2025 – Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share. This declaration, coming on the heels of a consistently strong financial performance, reaffirms the company's
SANTA CLARA, CA – November 19, 2025 – Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, today announced that its Board of Directors has declared a quarterly dividend of 25.5 cents per share of common stock. This latest declaration underscores the company's robust
Dan Loeb's Third Point doubled its Microsoft stake and boosted Meta, Amazon, and Nvidia while fully exiting Workday and multiple industrial names in Q3.
And What It Means for Investors and the Water Technology Sector
Xylem Inc. (NYSE: XYL), a global leader in water technology, demonstrated its robust financial health and commitment to shareholder returns by declaring a first-quarter dividend of $0.40 per share. Announced on February 4, 2025, this represents an 11%
Discover the Caviar Cruise strategy for finding quality long-term investments. See how Danaher Corp exemplifies this approach with strong growth, high returns, and solid finances.
Waltham, MA – November 6, 2025 – Thermo Fisher Scientific Inc. (NYSE: TMO), a global leader in scientific instrumentation, laboratory services, and diagnostic solutions, today announced its latest quarterly cash dividend of $0.43 per common share. This declaration, coming from a company with a robust track record of financial performance and
Even if a company is profitable, it doesn’t always mean it’s a great investment.
Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
Avantor (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries, saw its shares tumble by a staggering 17.4% on Wednesday, October 29, 2025. The precipitous decline followed the release of its third-quarter earnings
